申请人:Phenex-FXR GmbH
公开号:US20210147398A1
公开(公告)日:2021-05-20
The present invention relates to bicyclic compounds (e.g. indoles) containing a sulfonyl moiety, which bind to the liver X receptor (LXRα and/or LXKβ) and act preferably as inverse agonists of LXR.